News

Pharmacy Sector Faces Challenges Amidst Growth Projections

Pharmacy Sector Faces Challenges Amidst Growth Projections

Pharmacy Sector Faces Challenges Amidst Growth Projections

The infusion and specialty pharmacy markets are currently navigating complex challenges, which include rising operational costs and reimbursement issues. As pharmacies strive to provide outstanding patient care while maintaining profitability, they are feeling the pressure from a variety of directions. This environment highlights the urgent need for pharmacies to innovate and adapt to remain competitive.

Growing Market Projections

Analysts predict that the home infusion market will experience a compound annual growth rate (CAGR) of approximately 7% to 8% in the coming years, with the specialty pharmacy sector seeing even quicker growth at an anticipated rate of 10% through 2035. These market projections signal a promising future; however, it is crucial for pharmacies to develop robust revenue cycle management (RCM) strategies to secure their long-term growth and success.

Understanding Pharmacy Needs for Effective RCM

To better comprehend the requirements of pharmacy providers and the factors driving an effective RCM strategy, an insightful research report was released detailing the evolving state of the infusion and specialty pharmacy market. This comprehensive study highlights pressing pain points, emergent trends, and the increasing reliance on partners with substantial expertise to enhance efficiency and cut costs.

Key Findings from the Research

Among the critical takeaways from the report are:

  • 73% of surveyed providers expressed dissatisfaction with their current RCM strategies. Common frustrations included high denial rates, aging accounts receivable balances, and escalating write-offs that adversely affect profitability.
  • Many respondents reported revenue losses linked to inefficient RCM processes. Notably, 50% indicated limited revenue growth as a top concern, while 43% cited staff turnover due to frustration with RCM operations.
  • Looking ahead, 68% of pharmacies highlighted reducing denials and appeals as their most significant RCM challenge for the next two years. Trailing closely is the difficulty in adhering to complex payer rules, identified by 44% of pharmacies.

The Shift Towards Outsourcing RCM Services

In light of these challenges, many pharmacy providers are increasingly turning to external RCM partners to address their needs. An impressive 82% of respondents reported outsourcing at least one RCM function, citing limited resources or a lack of specialized expertise as the main driving factor. The research further revealed that the top three attributes pharmacy providers value in an RCM partner are effective revenue capture, transparency into performance metrics, and industry expertise.

Embracing a Proactive RCM Approach

Industry leaders, such as Prochant, emphasize the necessity for infusion pharmacy providers to adopt a proactive strategy in their RCM practices. They encourage leveraging teams with extensive expertise and advanced technology, including real-time analytics and AI-powered tools, to enhance workflows. This strategic alignment is vital for pharmacies to not only survive but thrive in a complex market landscape.

Direct Support and Resources

For stakeholders interested in learning more about the infusion pharmacy industry, accessing comprehensive resources and actionable insights is essential. The detailed findings from this report provide numerous recommendations that can aid pharmacies in optimizing their operational effectiveness and financial stability.

Frequently Asked Questions

What are the main challenges pharmacies face today?

Pharmacies are grappling with rising operational costs, staffing shortages, and inefficiencies in their revenue cycle management processes which lead to reduced profitability.

How fast is the specialty pharmacy market expected to grow?

The specialty pharmacy market is projected to grow at a compound annual growth rate of 10% through 2035.

Why do pharmacies turn to outsourced RCM partners?

Pharmacies often seek external RCM partners due to resource limitations and the need for specialized expertise to improve operational efficiency.

What percentage of providers are unhappy with their RCM approach?

73% of pharmacy providers surveyed reported being less than fully satisfied with their current revenue cycle management strategies.

What tools can help pharmacies in RCM?

Utilizing advanced tools such as real-time analytics and AI-driven workflows can help pharmacies streamline their revenue cycle management and enhance overall operational efficiency.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring CRH Stock Performance Over Five Years and Beyond

Updated Category News Views 152

Understanding CRH's Impressive Growth CRH has displayed a remarkable performance in the stock market over the last five years, outshining many of its competitors with a 10.67% annualized return. This impressive growth translates to an average annual return of 23.49% for investors. Currently, CRH boasts a market capitalization of approximately $73.09 billion, making it a...

Continue Reading
Coordinated Care's Health Tour Expands Access Across WA

Updated Category News Views 78

A Grassroots Push for Health Equity Coordinated Care, a subsidiary of Centene Corporation, is hitting the road in Washington state. This isn't about just another healthcare campaign—you’ve got two vans, 'SeeMore' and 'Flossy', bringing essential vision and dental screenings right up to the folks who need them most. Taking Healthcare Directly to Communities Let's be...

Continue Reading
Italy's Antitrust Agency Investigates Snam-Edison Deal

Updated Category News Views 229

Investigation into the Snam and Edison Gas Storage Deal Italy's antitrust agency has recently initiated an investigation concerning the transaction between Snam and Edison involving Edison's gas storage unit. This move reflects the agency's commitment to maintaining healthy competition within the energy sector. Concerns Over Market Competition The Antitrust Authority,...

Continue Reading
Truist Financial Corporation's Quarterly Performance Insights

Updated Category News Views 240

Truist Financial's Results and Earnings Overview Truist Financial Corporation (TFC) announced its latest quarterly results, showcasing a robust financial performance that illustrates the company’s strategic focus on growth and stability. This release reflects the commitment of Truist to enhance the lives of its clients and communities by providing comprehensive...

Continue Reading
Investigation Into Possible Securities Fraud at UnitedHealth Group

Updated Category News Views 350

UnitedHealth Group Under Scrutiny for Securities Claims Ademi & Fruchter LLP has launched an investigation into potential securities fraud claims against UnitedHealth Group Incorporated (NYSE: UNH). This inquiry arises following inaccurate statements made by the company regarding its operational performance and future outlook. Investors and analysts alike express serious...

Continue Reading